BioLight Life Sciences Ltd. (BOLT.TA)

ILA 642.0

(1.28%)

Total Assets Summary of BioLight Life Sciences Ltd.

BioLight Life Sciences Ltd.'s latest annual total assets in 2023 was 33.45 Million ILS , down -41.32% from previous year.
BioLight Life Sciences Ltd.'s latest quarterly total assets in 2024 Q2 was 35.78 Million ILS , down 0.0% from previous quarter.
BioLight Life Sciences Ltd. reported annual total assets of 57.01 Million ILS in 2022, down -11.16% from previous year.
BioLight Life Sciences Ltd. reported annual total assets of 64.17 Million ILS in 2021, down -1.01% from previous year.
BioLight Life Sciences Ltd. reported quarterly total assets of 33.45 Million ILS for 2023 Q4, down 0.0% from previous quarter.
BioLight Life Sciences Ltd. reported quarterly total assets of 93.56 Million ILS for 2023 Q2, down 0.0% from previous quarter.

Annual Total Assets Chart of BioLight Life Sciences Ltd. (2023 - 2013)

Historical Annual Total Assets of BioLight Life Sciences Ltd. (2023 - 2013)

Year	Total Assets	Total Assets Growth
2023	33.45 Million ILS	-41.32%
2022	57.01 Million ILS	-11.16%
2021	64.17 Million ILS	-1.01%
2020	64.82 Million ILS	-13.5%
2019	74.95 Million ILS	-16.98%
2018	90.28 Million ILS	264.58%
2017	24.76 Million ILS	-29.88%
2016	35.31 Million ILS	-44.19%
2015	63.27 Million ILS	56.48%
2014	40.43 Million ILS	17.77%
2013	34.33 Million ILS	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	35.78 Million ILS	0.0%
2023 Q4	33.45 Million ILS	0.0%
2023 Q2	93.56 Million ILS	0.0%
2023 FY	33.45 Million ILS	-41.32%
2022 Q4	57.01 Million ILS	0.0%
2022 Q2	66 Million ILS	0.0%
2022 FY	57.01 Million ILS	-11.16%
2021 Q2	70.78 Million ILS	0.0%
2021 Q4	64.17 Million ILS	0.0%
2021 FY	64.17 Million ILS	-1.01%
2020 Q4	64.82 Million ILS	-2.25%
2020 Q1	74.79 Million ILS	-0.21%
2020 Q3	66.32 Million ILS	-6.04%
2020 FY	64.82 Million ILS	-13.5%
2020 Q2	70.59 Million ILS	-5.62%
2019 Q4	74.95 Million ILS	-2.47%
2019 FY	74.95 Million ILS	-16.98%
2019 Q3	76.84 Million ILS	-7.47%
2019 Q2	83.05 Million ILS	-3.45%
2019 Q1	86.02 Million ILS	-4.72%
2018 Q4	90.28 Million ILS	-6.48%
2018 FY	90.28 Million ILS	264.58%
2018 Q3	96.53 Million ILS	97.55%
2018 Q2	48.86 Million ILS	14.17%
2018 Q1	42.8 Million ILS	72.84%
2017 Q3	29.43 Million ILS	-14.72%
2017 FY	24.76 Million ILS	-29.88%
2017 Q1	29.26 Million ILS	-17.13%
2017 Q2	34.51 Million ILS	17.94%
2017 Q4	24.76 Million ILS	-15.86%
2016 FY	35.31 Million ILS	-44.19%
2016 Q4	35.31 Million ILS	-16.51%
2016 Q3	42.29 Million ILS	-9.62%
2016 Q2	46.79 Million ILS	-12.03%
2016 Q1	53.19 Million ILS	-15.92%
2015 Q3	47.95 Million ILS	-9.96%
2015 Q4	63.27 Million ILS	31.95%
2015 Q2	53.25 Million ILS	0.0%
2015 FY	63.27 Million ILS	56.48%
2014 FY	40.43 Million ILS	17.77%
2014 Q4	40.43 Million ILS	0.0%
2014 Q2	54.24 Million ILS	0.0%
2013 Q2	48.39 Million ILS	0.0%
2013 Q4	34.33 Million ILS	0.0%
2013 FY	34.33 Million ILS	0.0%

Peer Total Assets Comparison of BioLight Life Sciences Ltd.

Name	Total Assets	Total Assets Difference
Matricelf Ltd	39.49 Million ILA	15.299%